DE69716414T2 - Benzoxazine zur erhöhung der synaptischen reaktionen - Google Patents
Benzoxazine zur erhöhung der synaptischen reaktionenInfo
- Publication number
- DE69716414T2 DE69716414T2 DE69716414T DE69716414T DE69716414T2 DE 69716414 T2 DE69716414 T2 DE 69716414T2 DE 69716414 T DE69716414 T DE 69716414T DE 69716414 T DE69716414 T DE 69716414T DE 69716414 T2 DE69716414 T2 DE 69716414T2
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- subjects
- ampa receptors
- benzoxazine
- reactions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/624,335 US5736543A (en) | 1996-04-03 | 1996-04-03 | Benzoxazines for enhancing synaptic response |
PCT/US1997/005184 WO1997036907A1 (en) | 1996-04-03 | 1997-03-28 | Benzoxazines for enhancing synaptic response |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69716414D1 DE69716414D1 (de) | 2002-11-21 |
DE69716414T2 true DE69716414T2 (de) | 2003-06-12 |
Family
ID=24501596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69716414T Expired - Lifetime DE69716414T2 (de) | 1996-04-03 | 1997-03-28 | Benzoxazine zur erhöhung der synaptischen reaktionen |
Country Status (10)
Country | Link |
---|---|
US (2) | US5736543A (de) |
EP (1) | EP0891365B1 (de) |
JP (1) | JP3170294B2 (de) |
AT (1) | ATE226206T1 (de) |
AU (1) | AU708212B2 (de) |
DE (1) | DE69716414T2 (de) |
DK (1) | DK0891365T3 (de) |
ES (1) | ES2185932T3 (de) |
NZ (1) | NZ331992A (de) |
WO (1) | WO1997036907A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU721936B2 (en) * | 1996-04-03 | 2000-07-20 | Regents Of The University Of California, The | Benzoxazines for enhancing synaptic response |
US6110935A (en) * | 1997-02-13 | 2000-08-29 | The Regents Of The University Of California | Benzofurazan compounds for enhancing glutamatergic synaptic responses |
PT1026950E (pt) * | 1997-10-27 | 2006-06-30 | Cortex Pharma Inc | Tratamento da esquizofrenia com ampaquinas e neurolepticos |
US5985871A (en) * | 1997-12-24 | 1999-11-16 | Cortex Pharmaceuticals, Inc. | Benzoxazine compounds for enhancing synaptic response |
US6943159B1 (en) | 1998-02-18 | 2005-09-13 | Neurosearch A/S | Compounds and their use as positive AMPA receptor modulators |
US6124278A (en) * | 1998-04-03 | 2000-09-26 | The Regents Of The University Of California | Acylbenzoxazines for enhancing synaptic response |
US6011991A (en) * | 1998-12-07 | 2000-01-04 | Technology Patents, Llc | Communication system and method including brain wave analysis and/or use of brain activity |
US7455836B2 (en) * | 2000-05-08 | 2008-11-25 | The University Of Melbourne | Method of treatment and agents useful for same |
TWI232863B (en) | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
KR100864267B1 (ko) * | 2001-06-14 | 2008-10-20 | 엔.브이.오가논 | AMPA 수용체의 양성 조절제로서의(피리도/티에노)-[f]-옥사제핀-5-온 유도체 |
SK2292004A3 (en) * | 2001-11-26 | 2004-09-08 | Cortex Pharma Inc | Carbonyl benzoxazine compounds for enhancement of glutamatergic synaptic responses |
RS20050202A (en) | 2002-09-09 | 2007-08-03 | Nektar Therapeuticals Al.Corporation, | Water-soluble polymer alkanals |
EA200501117A1 (ru) | 2003-01-13 | 2006-02-24 | Кортекс Фармасеутикалс, Инк. | Способ лечения снижения когнитивной способности вследствие лишения сна и стресса |
US20060063707A1 (en) * | 2004-09-17 | 2006-03-23 | Lifelike Biomatic, Inc. | Compositions for enhancing memory and methods therefor |
TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
EP2083921A2 (de) | 2006-09-04 | 2009-08-05 | Neurosearch A/S | Pharmazeutische kombinationen aus einem nikotinrezeptormodulator und einem mittel zur intensivierung kognitiver funktionen |
JP5139446B2 (ja) * | 2007-01-03 | 2013-02-06 | レ ラボラトワール セルヴィエ | グルタミン酸作動性シナプス応答を増強する3−置換−[1,2,3]−ベンゾトリアジノン化合物 |
AP2009004915A0 (en) * | 2007-01-03 | 2009-08-31 | Cortex Pharma Inc | 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses |
CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
MX2009009937A (es) * | 2007-03-23 | 2009-09-24 | Univ California | Tratamiento de la disfuncion sexual femenina mediante compuestos que modulan de manera positiva los receptores de glutamato tipo ampa. |
ES2657054T3 (es) * | 2007-05-17 | 2018-03-01 | Respirerx Pharmaceuticals Inc. | Amidas disustituidas para mejorar las respuestas sinápticas glutamatérgicas |
US8168632B2 (en) * | 2007-08-10 | 2012-05-01 | Cortex Pharmaceuticals, Inc. | Bicyclic amide derivatives for the treatment of respiratory disorders |
WO2009023126A2 (en) | 2007-08-10 | 2009-02-19 | Cortex Pharmaceuticals, Inc. | Bicyclic amides for enhancing glutamatergic synaptic responses |
US8071914B2 (en) | 2007-12-26 | 2011-12-06 | Noboru Oshima | Heating apparatus |
WO2010054336A2 (en) * | 2008-11-10 | 2010-05-14 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
EP2544688B1 (de) | 2010-03-02 | 2016-09-07 | President and Fellows of Harvard College | Verfahren und zusammensetzungen zur behandlung des angelman-syndroms |
WO2012121971A2 (en) | 2011-03-04 | 2012-09-13 | The Regents Of The University Of California | Locally released growth factors to mediate motor recovery after stroke |
US10555916B2 (en) | 2013-01-25 | 2020-02-11 | Case Western Reserve University | NMDAR antagonist for the treatment of pervasive development disorders |
MX2015017253A (es) | 2013-06-13 | 2016-04-19 | Veroscience Llc | Composiciones y metodos para tratar trastornos metabolicos. |
CN107286114B (zh) | 2016-04-13 | 2020-08-18 | 中国人民解放军军事医学科学院毒物药物研究所 | Ampa受体增效剂的脑靶向前药及其医药用途 |
WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
WO2020056418A1 (en) | 2018-09-14 | 2020-03-19 | Neuroenhancement Lab, LLC | System and method of improving sleep |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3257396A (en) * | 1962-06-11 | 1966-06-21 | Geigy Chem Corp | Certain 1, 3-benzoxazinone derivatives |
ATE253909T1 (de) * | 1992-07-24 | 2003-11-15 | Univ California | Arzneimittel die den durch ampa rezeptoren vermittelten synaptischen response erhöhen |
US5650409A (en) * | 1995-06-02 | 1997-07-22 | Cortex Pharmaceuticals, Inc. | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
-
1996
- 1996-04-03 US US08/624,335 patent/US5736543A/en not_active Expired - Lifetime
-
1997
- 1997-03-28 DE DE69716414T patent/DE69716414T2/de not_active Expired - Lifetime
- 1997-03-28 AT AT97919965T patent/ATE226206T1/de not_active IP Right Cessation
- 1997-03-28 AU AU24274/97A patent/AU708212B2/en not_active Ceased
- 1997-03-28 JP JP53548897A patent/JP3170294B2/ja not_active Expired - Fee Related
- 1997-03-28 EP EP97919965A patent/EP0891365B1/de not_active Expired - Lifetime
- 1997-03-28 DK DK97919965T patent/DK0891365T3/da active
- 1997-03-28 ES ES97919965T patent/ES2185932T3/es not_active Expired - Lifetime
- 1997-03-28 NZ NZ331992A patent/NZ331992A/xx unknown
- 1997-03-28 WO PCT/US1997/005184 patent/WO1997036907A1/en active IP Right Grant
-
1998
- 1998-02-06 US US09/019,883 patent/US5962447A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0891365T3 (da) | 2003-02-10 |
ATE226206T1 (de) | 2002-11-15 |
JP3170294B2 (ja) | 2001-05-28 |
US5736543A (en) | 1998-04-07 |
EP0891365B1 (de) | 2002-10-16 |
ES2185932T3 (es) | 2003-05-01 |
EP0891365A1 (de) | 1999-01-20 |
US5962447A (en) | 1999-10-05 |
AU2427497A (en) | 1997-10-22 |
AU708212B2 (en) | 1999-07-29 |
NZ331992A (en) | 1999-02-25 |
JP2000503664A (ja) | 2000-03-28 |
DE69716414D1 (de) | 2002-11-21 |
WO1997036907A1 (en) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69716414D1 (de) | Benzoxazine zur erhöhung der synaptischen reaktionen | |
PT839134E (pt) | Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica | |
CA2138533A1 (en) | Drugs that enhance synaptic responses mediated by ampa receptors | |
PL341427A1 (en) | Benzoxazinic compounds for enhancing sybaptic response | |
DK1355669T3 (da) | Forbedret kognitiv træning | |
DE69834590D1 (de) | Benzofurazanderivate und deren verwendung zur verbesserung glutaminerger synaptischer antworten | |
DE69910552D1 (de) | Acylbenzoxazine zur erhöhung der synaptischen reaktion(en) | |
EA200400584A1 (ru) | Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов | |
CA2249654A1 (en) | Benzoxazines for enhancing synaptic response |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee | ||
8370 | Indication related to discontinuation of the patent is to be deleted |